CYP3A5 and MDR1 Genotyping
1 clinical trials · Condition
◉ Watch CYP3A5 and MDR1 Genotyping
| Record | Firm | Date |
|---|---|---|
| Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events (NCT01110291) | University of Turku | 2003-04-01 |
Track CYP3A5 and MDR1 Genotyping automatically
Every clearance here is in the API, with alerts when new ones post.